Kazia Therapeutics expands oncology platform with first-in-class SETDB1 inhibitor drug development platform: Sydney, Australia Wednesday, April 15, 2026, 15:00 Hrs [IST] Kazia The ...
Back in 1942, the term epigenetics was introduced by Conrad Waddington to present a picture of cell development, one in which cells descended a hillside and followed diverging valley paths before ...
Chromatin is one of the earliest identified targets for cancer therapeutics. Drug development aimed at altering chromatin can be traced to the differentiating agents of the 1970s and their link to DNA ...
Kazia Therapeutics (NASDAQ: KZIA), a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, today announced the appointment of Dr. Sudha Rao as Chief ...
Epigenetics, the study of changes in gene function that do not involve alterations to the DNA sequence, plays a pivotal role in understanding the complex interplay between genetics and the environment ...
Dr Aaron Wenger reveals how improvements in long-read sequencing technology is enabling the elucidation of complex disease ...
Copenhagen, March, 2025 - The University of Copenhagen is excited to announce TruDiagnostic, a leader in epigenetic testing, will present its latest advancements at the 12th Aging Research and Drug ...
SHANGHAI, Sept. 7, 2025 /PRNewswire/ -- Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series B round of ...
A study published in Briefings in Functional Genomics investigated how epigenetics can modulate human's genetic program -- it can emphasize or silence genes. The new research shows that if epigenetics ...
Epigenetics, the study of changes in gene function that do not involve alterations to the DNA sequence, plays a pivotal role in understanding the complex interplay between genetics and the environment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results